Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$0 Hold
4
﹤0.01% 1577
2017
Q1
$0 Hold
4
﹤0.01% 1525
2016
Q4
$0 Hold
4
﹤0.01% 1596
2016
Q3
$0 Hold
4
﹤0.01% 1602
2016
Q2
$0 Hold
4
﹤0.01% 1594
2016
Q1
$0 Buy
+4
New +$67 ﹤0.01% 1556
2015
Q1
Sell
-2,680
Closed -$37K 1829
2014
Q4
$37K Hold
2,680
0.01% 994
2014
Q3
$27K Hold
2,680
0.01% 1156
2014
Q2
$27K Hold
2,680
0.01% 1144
2014
Q1
$28K Hold
2,680
0.01% 1123
2013
Q4
$24K Hold
2,680
﹤0.01% 1269
2013
Q3
$19K Buy
2,680
+1,860
+227% +$11.8K ﹤0.01% 1296
2013
Q2
$5K Buy
+820
New +$3.93K ﹤0.01% 1655

Other funds holding DXCM

WFG Advisors's DXCM Position: Q2 2017 in Review

WFG Advisors held its DexCom (DXCM) position steady in Q2 2017 at 4 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1577.

WFG Advisors first reported a position in DXCM in Q2 2013 and has held it in 13 quarters since. The position peaked at $37K in Q4 2014. 311 funds tracked by Wall St. Rank hold DXCM as of Q2 2017.

  • WFG Advisors held 4 shares of DexCom worth $0 as of Q2 2017.
  • WFG Advisors left its DexCom share count unchanged in Q2 2017.
  • DexCom made up ﹤0.01% of WFG Advisors's portfolio in Q2 2017, its #1577 holding.
  • WFG Advisors first reported a position in DexCom in Q2 2013 and has held it in 13 quarters since.
  • WFG Advisors's DexCom position peaked at $37K in Q4 2014.
  • 311 funds tracked by Wall St. Rank held DexCom as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.